Management Team

Averica Discovery Services, Inc.

Our management’s extensive industry experience can accelerate your R&D program


Jeffrey Kiplinger

Founder and General Manager, Averica & VP Science and Innovation, Neopharm Labs

Dr. Kiplinger has 25 years of experience in pharmaceutical and related industries, working extensively in the discovery and optimization of small molecule human and veterinary therapeutics. From 2001 through 2007, Dr. Kiplinger consulted with a variety of discovery technology companies on the optimization of chemistry discovery process. Previously, he founded the Gilson Center for Integrated Discovery Technology (CIDT) as a partnership development center responsible for high-speed chemistry and analysis products. From 1988 to 1998 at Pfizer, Dr. Kiplinger supported discovery chemistry activities by developing new applications for mass spectrometry and chromatography, in particular Open Access HPLC/MS and mass spectrometry-directed preparative chromatography.

Cynthia Berger

Vice President of Operations, Averica

Dr. Berger brings over 20 years of experience working in analytical contract research and instrumentation companies.  Prior to joining Averica Discovery, Dr. Berger served as Project Manager at PCI Synthesis, a contract manufacturing organization (CMO), where she managed million dollar projects developing drug substances.  Previously, she served as Vice President and Co-Founder of Pion, Inc., an instrumentation company and CRO, where she oversaw instrumentation sales, the CRO laboratory, and project management.  In addition to her responsibilities, Dr. Berger was a key contributor to the development of Pion’s instruments and intellectual property.  She also established new markets for the company, expanding their service offerings.  Dr. Berger earned her Ph.D. in Chemistry from Penn State University.

Mickey Rego

Business Development

Mickey joined Averica in 2009 after graduating from Merrimack College with a degree in Chemistry.  His responsibilities started with small molecule purification and grew to include method development, system analysis for suitability, and project management.  In the four years at Averica, Mickey became proficient in SFC, HPLC, LC/MS, SFC/MS, and NMR.  His qualifications attracted big pharma and in 2013 he joined AstraZeneca.  Mickey continued to enhance his analytical chemistry skills as part of both the Oncology and Infection Chemistry groups.  In 2015, Mickey rejoined Averica taking on a Business Development role.  The position offers an opportunity to use his knowledge of Averica capabilities and technical expertise to explore creative solutions to client’s problems, developing deep insight into each project’s criteria for success.

Jeff Solomon, CPA, CVA

Director, Finance

Mr. Solomon is the managing shareholder of Katz, Nannis, and Solomon, PC.

Walter Wright III

Corporate Counsel

Mr. Wright is a Managing Partner at Boston’s Trinity Law Group, which focuses on the organizational, venture financing, operational, capital and transactional requirements of entrepreneurs, start-ups, emerging, and mid-sized companies.